NRC Health NRC
$21.12
-$0.14-0.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.69% | -1.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.69% | -1.11% | |||
| Cost of Revenue | -0.60% | -2.07% | |||
| Gross Profit | 3.17% | -0.48% | |||
| SG&A Expenses | 47.44% | 72.26% | |||
| Depreciation & Amortization | -2.21% | 1.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.33% | 22.47% | |||
| Operating Income | -101.40% | -50.82% | |||
| Income Before Tax | -203.61% | 33.96% | |||
| Income Tax Expenses | -208.38% | -21.35% | |||
| Earnings from Continuing Operations | -201.89% | 79.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -201.89% | 79.20% | |||
| EBIT | -101.40% | -50.82% | |||
| EBITDA | -73.60% | -42.55% | |||
| EPS Basic | -205.93% | 83.55% | |||
| Normalized Basic EPS | -131.13% | -55.88% | |||
| EPS Diluted | -207.21% | 94.99% | |||
| Normalized Diluted EPS | -131.31% | -56.08% | |||
| Average Basic Shares Outstanding | 0.96% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.48% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -1.98% | -0.25% | |||